Distinct ETA receptor binding mode of macitentan as determined by site directed mutagenesis - Wikidata - awgldk - TriplyDB

Distinct ETA receptor binding mode of macitentan as determined by site directed mutagenesis

Distinct ETA receptor binding mode of macitentan as determined by site directed mutagenesis

http://www.wikidata.org/entity/Q35256194

about

Incident and prevalent cohorts with pulmonary arterial hypertension: insight from SERAPHIN Endothelin research and the discovery of macitentan for the treatment of pulmonary arterial hypertension.Development of macitentan for the treatment of pulmonary arterial hypertension.Comparison of Macitentan and Bosentan on Right Ventricular Remodeling in a Rat Model of Non-vasoreactive Pulmonary Hypertension.The metabolism of the dual endothelin receptor antagonist macitentan in rat and dog.X-ray structures of endothelin ETB receptor bound to clinical antagonist bosentan and its analog.Lack of Pharmacokinetic Interactions Between Macitentan and a Combined Oral Contraceptive in Healthy Female Subjects.

P2860

Q36332690-B6B75BD9-1BA9-49EB-BFDC-E9455B123A51 Q38559413-D809CDEF-A88E-4158-BFA3-08D5814B5CB5 Q38570060-84E5921F-2E5C-4144-B059-69D8B11B07BE Q42248306-28CAD4BA-24E4-4648-9302-3539EA41C6E0 Q46674601-5288ED0E-552D-4C00-B471-7FA5CA35CEAC Q47929318-5AD0B9DC-68B9-483B-B585-E49D0EFEEBAB Q50982502-A1D6D763-EBE8-44B4-AF30-6E286C5B6A1C

P2860

Distinct ETA receptor binding mode of macitentan as determined by site directed mutagenesis

http://www.wikidata.org/entity/Q35256194

description

2014 nî lūn-bûn

@nan

2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Distinct ETA receptor binding ...... d by site directed mutagenesis

@ast

Distinct ETA receptor binding ...... d by site directed mutagenesis

@en

type

label

Distinct ETA receptor binding ...... d by site directed mutagenesis

@ast

Distinct ETA receptor binding ...... d by site directed mutagenesis

@en

prefLabel

Distinct ETA receptor binding ...... d by site directed mutagenesis

@ast

Distinct ETA receptor binding ...... d by site directed mutagenesis

@en

P1433

Q35256194-0647304B-1A0F-4C11-BB7A-307AC6A09BA4

P1476

Q35256194-297F25F2-FA35-4BA8-8624-8D9A59E1A021

P2093

Q35256194-3B1469F6-865F-4157-9286-D147A40E9216

Q35256194-3B1AB0D6-4667-40C5-A7BE-4CCC802CA051

Q35256194-7B1421A2-56F4-4A81-965A-5661C4AF5F36

Q35256194-80D44107-580E-474E-934D-5A155E301448

Q35256194-A7975237-A68D-420D-98F6-7561CEE48ED1

P2860

Q35256194-0149CA38-D2DC-47B3-BAA6-56002BF4B0A5

Q35256194-0FF89214-7A24-43B2-BE82-543F1AF20D4B

Q35256194-190EEEB8-0EF9-4487-A8DD-7A315D2BB7C3

Q35256194-21512570-F05A-4642-B64D-7706BAE42BDE

Q35256194-4C60EE12-E5C8-4D83-AF40-85A4FBC0977C

Q35256194-500E0510-E6E6-4270-A17F-3E1B5D03E934

Q35256194-525F6940-32EB-465D-914C-EC4769A4E58A

Q35256194-52781458-EB28-49A6-9389-6DB47C44922C

Q35256194-5B32A44A-0201-431D-AD43-3AE272ACBCA1

Q35256194-616F6210-DC94-4D6F-8D6D-CB798A6414E1

P304

Q35256194-7C62EAC6-7728-46F8-A8D3-F94ADDF0DB9A

P31

Q35256194-5BCE20A6-0BB4-4874-A6A0-D90FE9E523AD

P356

Q35256194-8B65B2BE-C5EC-44A4-A200-F08B5CC79F3D

P407

Q35256194-C337D9C3-A630-49A3-9E47-AA5EBD2C3A73

P433

Q35256194-58553024-F629-4EA7-B4FD-157C04FF4C36

P478

Q35256194-974531DA-CCD7-4F48-ABC5-1FC927E70CE4

P577

Q35256194-EF7854B0-1DD6-497B-956F-92CECA361383

P5875

Q35256194-04D853A5-B179-4FEC-8911-A7266BF9485E

P698

Q35256194-22ACB234-4875-4925-8EBE-F96ECEF46BDF

P932

Q35256194-E76E04A4-E348-4180-8A39-023D614ACE55

P356

JOURNAL.PONE.0107809

P1433

P1476

Distinct ETA receptor binding ...... d by site directed mutagenesis

@en

P2093

Celia Mueller Grandjean

http://www.w3.org/2001/XMLSchema#string

Daniel Bur

http://www.w3.org/2001/XMLSchema#string

John Gatfield

http://www.w3.org/2001/XMLSchema#string

Martin H Bolli

http://www.w3.org/2001/XMLSchema#string

Oliver Nayler

http://www.w3.org/2001/XMLSchema#string

P2860

Slow receptor dissociation kinetics differentiate macitentan from other endothelin receptor antagonists in pulmonary arterial smooth muscle cells

High-resolution crystal structure of human protease-activated receptor 1

Structure of the nociceptin/orphanin FQ receptor in complex with a peptide mimetic

Structure of the δ-opioid receptor bound to naltrindole

Molecular cloning of a non-isopeptide-selective human endothelin receptor

Cloning and expression of human endothelin-1 receptor cDNA

Stimuli of sensory-motor nerves terminate arterial contractile effects of endothelin-1 by CGRP and dissociation of ET-1/ET(A)-receptor complexes

Fundamental aspects of protein-protein association kinetics

Modern homology modeling of G-protein coupled receptors: which structural template to use?

Drug-target residence time: critical information for lead optimization.

P304

e107809

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0107809

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P577

2014-09-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

265691872

http://www.w3.org/2001/XMLSchema#string

P698

25226600

http://www.w3.org/2001/XMLSchema#string

P932

4166607

http://www.w3.org/2001/XMLSchema#string